Yahoo Finance Live anchors Akiko Fujita and Seana Smith break down Monday's top headlines, including Meta being fined $1.3 billion, Pfizer's weight loss study, and retailers set to report earnings on
Yahoo Finance's Rachelle Akuffo details a rise in Pfizer stock after the company announced positive results from the study of a new weight loss drug.
U.S. equities ended mixed on Monday, May 22, 2023 before President Biden and Speaker McCarthy were set to meet to negotiate an end to the debt ceiling stalemate.

Why Pfizer Stock Crushed the Market on Monday

05:31pm, Monday, 22'nd May 2023
A medical journal detailed some very encouraging results of a diabetes and weight-loss investigational drug. In a phase 2 clinical trial, it produced results comparable to a very successful commercial
Evan Seigerman, BMO Capital Markets, joins 'Closing Bell Overtime' to discuss his 'Buy' rating on Pfizer, the weight-loss drug space, and more.
Pfizer's experimental diabetes treatment helped patients lose weight similar to Ozempic, but in less time.
Pfizer PFE, +4.09% stock was up 4.2% on Monday after a study of its diabetes treatment danuglipron found that a high dose of the drug reduced body weight by more than nine pounds over 16 weeks. The re
Yahoo Finance Live's Rachelle Akuffo breaks down the top trending tickers, including Plug Power announcing three deals in Europe and Pfizer's weight loss drug.
An oral drug from Pfizer led to faster weight loss than weekly injections of Novo Nordisk's diabetes drug Ozempic. Pfizer stock jumped.
Pfizer and Moderna are ushering in a new era for their Covid shots that aims to simplify what people need to do to coexist with the virus.
Pfizer Inc's diabetes drug resulted in weight loss similar to that of Novo Nordisk's Ozempic in a mid-stage study testing it in patients with type 2 diabates, according to a study published in JAMA ne
Pfizer is making its largest-ever debt issuance. It's going to use the proceeds to acquire Seagen.
Danuglipron, made by Pfizer could offer an advantage as an oral treatment option for weight loss over a frequent injection of Ozempic, made by Novo Nordisk.
Pfizer has fallen through the $40 level and looks very enticing as its dividend yield sits at 4.5%. Pfizer has been a dividend gem, paying a dividend since 1980, and its current dividend has 12 years
Healthcare stocks are an attractive prospect right now. Nearly 18% of the U.S. GDP went toward healthcare in 2021, which will only continue growing as the population gets older and sicker.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE